Citation Tools

Download PDFPDF

TP007/#1383  A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)
Free

Download to a citation manager

Cite this article as:
Alsomairi A, Lee J, Lee YJ, et al
TP007/#1383  A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)